1. Home
  2. LOB vs NVAX Comparison

LOB vs NVAX Comparison

Compare LOB & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$35.32

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
NVAX
Founded
2008
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
LOB
NVAX
Price
$35.32
$6.82
Analyst Decision
Hold
Hold
Analyst Count
3
8
Target Price
$40.00
$9.75
AVG Volume (30 Days)
310.6K
3.1M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
0.34%
N/A
EPS Growth
N/A
N/A
EPS
1.49
2.07
Revenue
$434,209,000.00
$1,064,651,000.00
Revenue This Year
$44.86
$58.91
Revenue Next Year
$16.20
N/A
P/E Ratio
$23.61
$3.30
Revenue Growth
7.02
20.27
52 Week Low
$22.68
$5.01
52 Week High
$41.56
$11.55

Technical Indicators

Market Signals
Indicator
LOB
NVAX
Relative Strength Index (RSI) 58.05 47.95
Support Level $35.90 $6.36
Resistance Level $36.73 $7.00
Average True Range (ATR) 0.83 0.22
MACD 0.08 0.07
Stochastic Oscillator 61.61 66.67

Price Performance

Historical Comparison
LOB
NVAX

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: